| P50 | author | Barbara Steiner | Q52085411 |
| | Andreas Kurtz | Q52882382 |
| | Manfred Gossen | Q63006891 |
| | Anne Schwerk | Q85000424 |
| P2093 | author name string | Christine Winter | |
| | Levent Akyüz | |
| | Jürgen Berg | |
| | Jennifer Altschüler | |
| | Manfred Roch | |
| P2860 | cites work | Neural stem cell niches in health and diseases | Q26995185 |
| | Immunobiology of mesenchymal stem cells | Q27004487 |
| | Staging of brain pathology related to sporadic Parkinson's disease | Q28131702 |
| | Reengineering biopharmaceuticals for targeted delivery across the blood-brain barrier | Q28257034 |
| | Interleukin-10 regulates progenitor differentiation and modulates neurogenesis in adult brain | Q28571642 |
| | Stromal-derived factor-1 (CXCL12) regulates laminar position of Cajal-Retzius cells in normal and dysplastic brains | Q28578487 |
| | Connexin 26 and basic fibroblast growth factor are expressed primarily in the subpial and subependymal layers in adult brain parenchyma: roles in stem cell proliferation and morphological plasticity? | Q28582333 |
| | Human mesenchymal stem cells reprogram adult cardiomyocytes toward a progenitor-like state through partial cell fusion and mitochondria transfer. | Q30513977 |
| | Nestin- and doublecortin-positive cells reside in adult spinal cord meninges and participate in injury-induced parenchymal reaction. | Q30525599 |
| | Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease. | Q31039577 |
| | Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation | Q33202256 |
| | Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention | Q33663970 |
| | Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue | Q33723606 |
| | Gene silencing as a threat to the success of gene therapy | Q33843166 |
| | Mesenchymal stem cells secrete multiple cytokines that promote angiogenesis and have contrasting effects on chemotaxis and apoptosis | Q34256627 |
| | Silencing of gene expression: implications for design of retrovirus vectors | Q34323213 |
| | Dopamine depletion impairs precursor cell proliferation in Parkinson disease. | Q34326801 |
| | Mesengenic potential and future clinical perspective of human processed lipoaspirate cells | Q35203286 |
| | In vivo tracking of stem cells for clinical trials in cardiovascular disease | Q35959118 |
| | Retrovirus silencing and vector design: relevance to normal and cancer stem cells? | Q36230366 |
| | In vivo evidence that erythropoietin protects neurons from ischemic damage | Q36477827 |
| | Behavioral models of Parkinson's disease in rodents: a new look at an old problem | Q36531775 |
| | Autologous transplants of Adipose-Derived Adult Stromal (ADAS) cells afford dopaminergic neuroprotection in a model of Parkinson's disease | Q36671837 |
| | The anterior olfactory nucleus in Parkinson's disease | Q36691553 |
| | Human interleukin-10 gene transfer is protective in a rat model of Parkinson's disease | Q37300999 |
| | Neurobiology and treatment of Parkinson's disease | Q37337617 |
| | Rodent models of Parkinson's disease: beyond the motor symptomatology | Q37343565 |
| | Mesenchymal stem cell homing: the devil is in the details | Q37407769 |
| | Expression of the insulin-like growth factor II gene in the choroid plexus and the leptomeninges of the adult rat central nervous system | Q37480311 |
| | Immunosuppressive properties of mesenchymal stem cells | Q37926524 |
| | Olfactory dysfunction in Parkinson disease | Q38009992 |
| | Human adipose-derived mesenchymal stromal cells increase endogenous neurogenesis in the rat subventricular zone acutely after 6-hydroxydopamine lesioning. | Q38302618 |
| | Mesenchymal stem cells augment neurogenesis in the subventricular zone and enhance differentiation of neural precursor cells into dopaminergic neurons in the substantia nigra of a parkinsonian model | Q39623128 |
| | Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat. | Q39776151 |
| | Reversal of dopaminergic degeneration in a parkinsonian rat following micrografting of human bone marrow-derived neural progenitors | Q39792829 |
| | alpha-Synucleinopathy in the human olfactory system in Parkinson's disease: involvement of calcium-binding protein- and substance P-positive cells. | Q39883880 |
| | AAV serotype 2/1-mediated gene delivery of anti-inflammatory interleukin-10 enhances neurogenesis and cognitive function in APP+PS1 mice | Q39893541 |
| | Neurorescue effects of VEGF on a rat model of Parkinson's disease | Q40393076 |
| | Glial cell line-derived neurotrophic factor in the substantia nigra from control and parkinsonian brains | Q40823270 |
| | Brain penetrating IgG-erythropoietin fusion protein is neuroprotective following intravenous treatment in Parkinson's disease in the mouse | Q42089098 |
| | The relation between cognition and motor dysfunction in drug-naive newly diagnosed patients with Parkinson's disease | Q42604425 |
| | Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson's disease. | Q43234179 |
| | Leptomeningeal-derived doublecortin-expressing cells in poststroke brain | Q43245986 |
| | Evaluation of senescence in mesenchymal stem cells isolated from equine bone marrow, adipose tissue, and umbilical cord tissue | Q44038136 |
| | Do adipose tissue-derived mesenchymal stem cells ameliorate Parkinson's disease in rat model? | Q46332910 |
| | Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease | Q46452329 |
| | Mesenchymal stem cells therapy exerts neuroprotection in a progressive animal model of Parkinson's disease | Q46456058 |
| | Neural differentiation ability of mesenchymal stromal cells from bone marrow and adipose tissue: a comparative study | Q47239479 |
| | Differential regulation of gliogenesis in the context of adult hippocampal neurogenesis in mice | Q48003056 |
| | Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease | Q48132256 |
| | Postnatal changes in the distribution and morphology of rat substantia nigra dopaminergic neurons | Q48135577 |
| | Biochemical and anatomical characterization of forepaw adjusting steps in rat models of Parkinson's disease: studies on medial forebrain bundle and striatal lesions | Q48240667 |
| | Parkinson's disease is associated with hippocampal atrophy | Q48275995 |
| | Intrahippocampal transplantation of mesenchymal stromal cells promotes neuroplasticity | Q48451318 |
| | Matrix metalloproteinase 2 (MMP2) and MMP9 secreted by erythropoietin-activated endothelial cells promote neural progenitor cell migration. | Q48515308 |
| | MPTP-induced hippocampal effects on serotonin, dopamine, neurotrophins, adult neurogenesis and depression-like behavior are partially influenced by fluoxetine in adult mice | Q48558309 |
| | Telocytes in meninges and choroid plexus. | Q48559999 |
| | Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease | Q48730943 |
| | Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. | Q48876521 |
| | Ischemia-induced neural stem/progenitor cells in the pia mater following cortical infarction | Q48951604 |
| | Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion | Q49047090 |
| | Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease. | Q50527409 |
| | Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoietic, and pro-inflammatory factors. | Q50685836 |
| | Cell-based therapies: from basic biology to replacement, repair, and regeneration. | Q50939047 |
| | Comparison of immunological properties of bone marrow stromal cells and adipose tissue-derived stem cells before and after osteogenic differentiation in vitro. | Q50998508 |
| | Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia. | Q51916987 |
| | Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. | Q51949961 |
| | Human adipose-derived mesenchymal stem cells improve motor functions and are neuroprotective in the 6-hydroxydopamine-rat model for Parkinson's disease when cultured in monolayer cultures but suppress hippocampal neurogenesis and hippocampal memory f | Q56966730 |
| P433 | issue | 4 | |
| P304 | page(s) | 431-446 | |
| P577 | publication date | 2015-05-01 | |
| P1433 | published in | Regenerative Medicine | Q19921466 |
| P1476 | title | Adipose-derived human mesenchymal stem cells induce long-term neurogenic and anti-inflammatory effects and improve cognitive but not motor performance in a rat model of Parkinson's disease | |
| P478 | volume | 10 | |